MetroWest Medical Center Completes First A-Fib Cryoablation Procedure

FRAMINGHAM – MetroWest Medical Center is expanding its heart health services to meet the needs of local residents. 

“Approximately 2.7 million Americans experience atrial fibrillation and our team has worked diligently to expand treatment options for this condition,” said Dr. Andrew Harding, CEO at MetroWest Medical Center.

“We believe it is important for local families to know that they do not have to go into the city for advanced, high-quality health care,” said Dr. Harding.

This common heart disorder occurs when electrical signals in the heart become irregular, causing the heart’s upper chamber to beat out of rhythm. Atrial fibrillation requires immediate medical attention because it could lead to a life-threatening stroke.

Atrial fibrillation may or may not cause symptoms. Some people with the disorder can have palpitations, chest pain, fatigue, shortness of breath, dizziness, or confusion. 

The condition is diagnosed through an electrocardiogram, which measures the heart’s electrical impulses.

Cryoablation is a process that uses extreme cold to disable abnormal heart tissue with a goal of reducing impact on healthy heart tissue and surrounding structures.

“The majority of patients we see with atrial fibrillation are candidates for ablation therapy,” said Dr. Patrick Blomberg, cardiologist (pictured). “We are excited to offer our patients this treatment option right here in our community.”

Framingham Source Editor Susan Petroni

Susan Petroni Framingham Source Editor Email: editor@FraminghamSource.com Phone: 508-315-7176

Leave a Reply